Deurloo EE, Klein Zeggelink WF, Teertstra HJ et al (2006) Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 16:692–701Deurloo EE, Klein Zeggelink WF, Teertstra HJ, et al. Contrast-enhanced MRI...
PET–MRI has been studied for the diagnosis, staging,and tumour phenotyping of breast cancer, and for theassessment of prognosis and treatment response. PET–MRI provides a comprehensive evaluation forpatients with newly diagnosed breast cancer, for whomthere is a clinical need to establish the exte...
We have successfully performed an MR screening study on 181 patients at high risk for breast cancer that did not have an actionable mammogram or clinical finding prior to study entry. Abnormal MRI findings prompted a total of 31 biopsies, 6 of which yielded malignant findings. The cancer yield...
Conference|Miami Breast Cancer Conference (MBCC) As part of our MBCC coverage we discuss MRI screening for breast cancer in patients who carry a BRCA mutation or have a first-degree relative who is a BRCA carrier. Sarah Mclaughlin, MD Your browser does not support the audio element. Today,...
[3]Curigliano G, Burstein HJ, P Winer E, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus on the primary therapy of early breast cancer 2017[J...
Breast magnetic resonance imaging (MRI) has been a very fast developing tool for the assessment of breast cancer and quickly moved from research to clinical settings. It is being used to evaluate patients with specific indications and as a screening tool for high-risk patients. The value of ...
"An MRI scan carried out once a year is therefore the only alternative for high-risk patients who have a strong family history ofbreast cancerto the surgical removal of the breast and ovaries," says Helbich. "This is by no means 'over-diagnosis', but rather a necessity. Around 13,000 ...
结直肠癌肝转移(colorectal cancer liver metastases,CRCLM)患者的5年生存率约为20%~30%,而未发生肝转移的患者5年生存率可达60%~80%[1]。此外,术前精准检测病灶大小、数量和部位是后续行转移灶切除术或消融术的关键[4]。因此,...
[5]Yu X, Hou J, Li F, et al. Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma[J]. J Magn Reson Imaging, 2016, 43(...
Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer[J]. JAMA Netw Open, 2020, 3(12): e2...